RCM Accretive Health

R1 RCM Appoints Rachel Wilson as Executive Vice President and Chief Financial Officer

R1 RCM Appoints Rachel Wilson as Executive Vice President and Chief Financial Officer

CHICAGO, May 04, 2020 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced the appointment of Rachel Wilson as Executive Vice President, Chief Financial Officer and Treasurer effective June 1, 2020.

Wilson will be responsible for the Finance function, including Investor Relations and Treasury. She brings 25 years of experience in capital markets, business finance, financial planning and analysis, and investment banking.  Most recently, she was the Chief Financial Officer for Iron Mountain Data Centers. Wilson brings deep experience in navigating complex global businesses and driving growth. Before joining Iron Mountain, she served as Vice President, Financial and Investor Relations, and Vice President of Corporate Development and Financial Relations for the Jarden Corporation. 

“R1 is driving the transformation of a critical function for healthcare providers, and I see significant opportunities ahead for the company,” said Wilson. “I look forward to working with the team to drive great results for our customers and continued strong execution for R1.”

“We are very pleased to have Rachel join the R1 team,” said Joe Flanagan, President and Chief Executive Officer of R1. “Rachel has significant experience in strategic financial planning, corporate development and treasury, and investor relations. Her business acumen and deep expertise across all facets of finance are critical to R1’s continued growth across our customers and product lines.”

“On behalf of myself and the entire Board of Directors, I would like to thank Rick Evans, interim CFO, for his time and commitment,” continued Flanagan. “He will continue as our Corporate Controller and Chief Accounting Officer on Rachel’s leadership team.”

About R1 RCM

R1 RCM is a leading provider of technology-enabled RCM services that transform and solve revenue cycle performance challenges across hospitals, health systems, and physician group practices. R1’s proven, and scalable operating models seamlessly complement a healthcare organization’s infrastructure, quickly driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. To learn more, visit: r1rcm.com.

Contacts:

Investor Relations

Atif Rahim

R1 RCM, Inc.

312-324-5476

Media Relations

Natalie Joslin

678.585.1206

 

EN
04/05/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Accretive Health

 PRESS RELEASE

TowerBrook and CD&R Complete Acquisition of R1 RCM

TowerBrook and CD&R Complete Acquisition of R1 RCM R1 RCM Becomes Privately Held Company; Joe Flanagan Reappointed as CEO MURRAY, Utah, Nov. 19, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (“R1”), a leader in automating revenue management for healthcare providers, today announced that investment funds affiliated with TowerBrook Capital Partners (“TowerBrook”) and Clayton, Dubilier & Rice (“CD&R”) have completed their previously announced acquisition of R1. On August 1, 2024, TowerBrook, CD&R and R1 announced that they had entered into a definitive merger agreement under which all outstanding ...

 PRESS RELEASE

R1 RCM Reports Third Quarter 2024 Results

R1 RCM Reports Third Quarter 2024 Results MURRAY, Utah, Nov. 05, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended September 30, 2024. Third Quarter 2024 Results: Revenue of $656.8 million, up $84.0 million or 14.7% compared to the same period last year.GAAP net loss of $19.9 million, compared to net income of $1.3 million in the same period last year.Adjusted EBITDA of $148...

 PRESS RELEASE

R1 RCM Reports Second Quarter 2024 Results

R1 RCM Reports Second Quarter 2024 Results MURRAY, Utah, Aug. 07, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended June 30, 2024. Second Quarter 2024 Results: Revenue of $627.9 million, up $67.2 million or 12.0% compared to the same period last year.GAAP net loss of $7.6 million, compared to net loss of $1.0 million in the same period las...

 PRESS RELEASE

R1 RCM to be Acquired by TowerBrook and CD&R for $8.9 Billion

R1 RCM to be Acquired by TowerBrook and CD&R for $8.9 Billion Stockholders to Receive $14.30 Per Share in Cash MURRAY, Utah, Aug. 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has entered into a definitive agreement to be acquired by investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice (“CD&R”), in an all-cash transaction with an enterprise value of approxi...

 PRESS RELEASE

R1 RCM Special Committee Provides Update on Evaluation of Strategic Al...

R1 RCM Special Committee Provides Update on Evaluation of Strategic Alternatives Sets Final Bid Deadline of July 31, 2024 MURRAY, Utah, July 24, 2024 (GLOBE NEWSWIRE) -- The Special Committee of the R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”) Board of Directors, which comprises independent directors and was formed to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C. (“New Mountain Capital”) with the Securities and Exchange Commission on February 26, 2024, today announced it has set a final deadline for interested parties to sub...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch